Search
for

    Glossary Basal Cell Carcinoma Treatment

    involves removing or destroying basal cell skin cancer

    Basal Cell Carcinoma Treatment (BCC Treatment) involves various methods to remove or destroy basal cell carcinoma, the most common type of skin cancer. Options include surgical excision, Mohs surgery (a precise technique that removes cancerous tissue layer by layer), cryotherapy (freezing the cancer cells), topical medications, and radiation therapy. The choice of treatment depends on the size, location, and depth of the carcinoma, as well as the patient's overall health.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects Journal of dermatological treatment · 2019 · 8 citations
    2. Treatment of multiple scalp basal cell carcinomas by photodynamic therapy Clinical and Experimental Dermatology · 2001 · 16 citations
    3. A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report Clinical Cosmetic and Investigational Dermatology · 2025
    4. Experiences with Smo antagonist vismodegib for the treatment of locally advanced basal cell carcinoma 2017
    5. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies American Journal of Clinical Dermatology · 2024 · 10 citations
    6. Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma Future oncology · 2016 · 28 citations
    7. A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma Journal of drugs in dermatology · 2021 · 25 citations
    8. Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study Dermatology and Therapy · 2026
    9. Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in Partial Response Despite Continuous Vismodegib Treatment Dermatologic Surgery · 2018 · 1 citations
    10. Senior Commentary to “Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma” Dermatologic Surgery · 2018
    11. Non-surgical treatments for basal cell skin cancer Vestnik dermatologii i venerologii · 2021 · 4 citations
    12. [Basal cell carcinomas of the scalp. Review of 77 patients with 81 tumors]. PubMed · 1988 · 3 citations
    13. 0748 Synergy of TP53 and non-canonical sonic hedgehog pathway in the development of complex basal cell carcinoma Journal of Investigative Dermatology · 2025
    14. Emerging drugs and combination strategies for basal cell carcinoma Expert opinion on emerging drugs · 2014 · 19 citations
    15. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis Molecular Medicine Reports · 2017 · 18 citations
    16. Scalp basal cell carcinoma: A different entity? Dermatologic Therapy · 2019 · 4 citations
    17. Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect Dermatopathology · 2024
    18. DMBA/TPA Treatment Is Necessary for BCC Formation from Patched Deficient Epidermal Cells in Ptch flox/flox CD4Cre +/− Mice Journal of Investigative Dermatology · 2014 · 11 citations
    19. Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses Journal of The American Academy of Dermatology · 2016
    20. Case Report: PTCH1 splice-site mutation and sonidegib treatment in Gorlin-Goltz syndrome: clinical insights from a family case study Frontiers in Medicine · 2026
    21. A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy Nature · 2018 · 105 citations
    22. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports Drugs in Context · 2022 · 9 citations
    23. Spreading of Isolated Ptch Mutant Basal Cell Carcinoma Precursors Is Physiologically Suppressed and Counteracts Tumor Formation in Mice International journal of molecular sciences · 2020 · 1 citations
    24. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice Journal of Clinical Investigation · 2004 · 64 citations
    25. Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened Clinical cancer research · 2011 · 63 citations
    26. Nevus comedonicus syndrome: a case associated with multiple basal cell carcinomas and a rudimentary toe International Journal of Dermatology · 2005 · 38 citations
    27. From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots British Journal of Dermatology · 2017 · 17 citations
    28. Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road Journal of Investigative Dermatology · 2014 · 15 citations
    29. Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease Cell Reports · 2022 · 14 citations
    30. Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice American Journal of Pathology · 2014 · 8 citations